Li-Li Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li-Li Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Sufan Wu
Center for Plastic and Reconstructive Surgery,Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China
2 shared publications - Yi Sun
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital(Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, China
2 shared publications Ji Wang
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College , Hangzhou, Zhejiang 310014
1 shared publication- Lei Zhang
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital)
1 shared publication Linjie Ye
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College , Hangzhou, Zhejiang 310014
1 shared publication- Miao-Yun Jiang
Hangzhou Normal University
1 shared publication
Latest Publications
- Open Access
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13, rbag095
Comparative regenerative mechanisms of adipose-derived mesenchymal stem cell- and conditioned medium-loaded three-dimensional bioprinted hydrogels in chronic diabetic wounds
Chronic diabetic wounds remain a major clinical challenge owing to impaired angiogenesis, persistent inflammation and cellular dysfunction. In this study, we developed a bioadhesive composite hydrogel scaffold (gelatin methacryloyl/alginate methacrylate [GA]) fabricated using digital light processing three-dimensional (3D) bioprinting, in which human adipose-derived mesenchymal stem cells (ADSCs) or their conditioned medium (CM) was incorporated to generate 3D skin constructs, and compared the paracrine effects on skin regeneration. We characterized the microstructures of GA-ADSC and GA-CM scaffolds; profiled CM proteins and systematically compared the effects of GA-ADSCs and GA-CM on fibroblast proliferation, migration, angiogenesis and macrophage polarization in vitro. Their therapeutic efficacy was further evaluated in diabetic mouse wound models, including analyses of collagen deposition, angiogenesis and fibrosis markers. Furthermore, proteomic analysis was performed to understand the underlying mechanisms. In vitro, both GA-ADSCs and GA-CM promoted fibroblast proliferation, migration, angiogenesis and macrophage M2 polarization. Moreover, they accelerated wound closure in diabetic mice by enhancing collagen deposition and neovascularization (CD31) and suppressing α-smooth muscle actin and transforming growth factor-β1 expression. Notably, GA-ADSCs showed prolonged cell viability and exhibited stronger immunomodulatory and antifibrotic effects than GA-CM. Proteomic analysis revealed distinct mechanistic differences: GA-ADSCs markedly activated Toll-like receptor signaling, necroptosis and extracellular matrix remodeling pathways, suggesting their key roles in immune regulation and metabolic reprogramming. In contrast, GA-CM primarily activated the Hippo signaling pathway, consistent with its role in growth factor-mediated tissue repair. Furthermore, we compared the differentially regulated proteins between ADSCs and CM in diabetic wounds and showed that ADSCs significantly modulated RGL2, RSPH9 and CRTC3, which are associated with enhanced cellular function and energy metabolism. These findings provide mechanistic insights into ADSC- and CM-mediated effects and support the development of bioinspired stem cell-based therapeutic strategies for chronic diabetic wound repair.
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13, rbag095
Open AccessComparative regenerative mechanisms of adipose-derived mesenchymal stem cell- and conditioned medium-loaded three-dimensional bioprinted hydrogels in chronic diabetic wounds
Chronic diabetic wounds remain a major clinical challenge owing to impaired angiogenesis, persistent inflammation and cellular dysfunction. In this study, we developed a bioadhesive composite hydrogel scaffold (gelatin methacryloyl/alginate methacrylate [GA]) fabricated using digital light processing three-dimensional (3D) bioprinting, in which human adipose-derived mesenchymal stem cells (ADSCs) or their conditioned medium (CM) was incorporated to generate 3D skin constructs, and compared the paracrine effects on skin regeneration. We characterized the microstructures of GA-ADSC and GA-CM scaffolds; profiled CM proteins and systematically compared the effects of GA-ADSCs and GA-CM on fibroblast proliferation, migration, angiogenesis and macrophage polarization in vitro. Their therapeutic efficacy was further evaluated in diabetic mouse wound models, including analyses of collagen deposition, angiogenesis and fibrosis markers. Furthermore, proteomic analysis was performed to understand the underlying mechanisms. In vitro, both GA-ADSCs and GA-CM promoted fibroblast proliferation, migration, angiogenesis and macrophage M2 polarization. Moreover, they accelerated wound closure in diabetic mice by enhancing collagen deposition and neovascularization (CD31) and suppressing α-smooth muscle actin and transforming growth factor-β1 expression. Notably, GA-ADSCs showed prolonged cell viability and exhibited stronger immunomodulatory and antifibrotic effects than GA-CM. Proteomic analysis revealed distinct mechanistic differences: GA-ADSCs markedly activated Toll-like receptor signaling, necroptosis and extracellular matrix remodeling pathways, suggesting their key roles in immune regulation and metabolic reprogramming. In contrast, GA-CM primarily activated the Hippo signaling pathway, consistent with its role in growth factor-mediated tissue repair. Furthermore, we compared the differentially regulated proteins between ADSCs and CM in diabetic wounds and showed that ADSCs significantly modulated RGL2, RSPH9 and CRTC3, which are associated with enhanced cellular function and energy metabolism. These findings provide mechanistic insights into ADSC- and CM-mediated effects and support the development of bioinspired stem cell-based therapeutic strategies for chronic diabetic wound repair.
- Open Access
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Polymers Au
- Vol. 6 (1) , 164-180
A Dual-Network Injectable Hydrogel Scaffold Integrating Glycyrrhizic Acid and Acellular Fat Extracts for Synergistic Enhancement of Diabetic Wound Healing
Chronic inflammation is a hallmark of diabetic wounds, severely disrupting the physiological healing cascade. Modulating this inflammatory microenvironment while ensuring biocompatibility remains a major challenge in regenerative medicine. Herein, we report the development of a multifunctional dual-network injectable hydrogel, incorporating glycyrrhizic acid (GA) and acellular fat extracts (FE), designed to enhance diabetic wound repair. The hydrogel comprises two interpenetrating networks: A reversible, dynamic network formed via Zn2+-coordinated GA confers excellent injectability and conformability, allowing tight adherence to irregular wound topographies. A secondary, physically cross-linked network is introduced by ultraviolet (UV)-induced polymerization of methacrylated hyaluronic acid (HAMA), which significantly reinforces mechanical strength and structural stability. GA exhibits inherent immunomodulatory activity, promoting macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, thereby attenuating local inflammation. Concurrently, FE provides a rich reservoir of pro-angiogenic and regenerative bioactive factors that synergistically promote neovascularization and tissue remodeling. In vitro and in vivo evaluations confirmed that this composite hydrogel accelerates wound closure, reduces inflammatory cytokine expression, enhances angiogenesis, and promotes granulation tissue formation. Collectively, this injectable, immunomodulatory, and pro-regenerative hydrogel platform offers a promising therapeutic strategy for the effective management of recalcitrant diabetic wounds.
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Polymers Au
- Vol. 6 (1) , 164-180
Open AccessA Dual-Network Injectable Hydrogel Scaffold Integrating Glycyrrhizic Acid and Acellular Fat Extracts for Synergistic Enhancement of Diabetic Wound Healing
Chronic inflammation is a hallmark of diabetic wounds, severely disrupting the physiological healing cascade. Modulating this inflammatory microenvironment while ensuring biocompatibility remains a major challenge in regenerative medicine. Herein, we report the development of a multifunctional dual-network injectable hydrogel, incorporating glycyrrhizic acid (GA) and acellular fat extracts (FE), designed to enhance diabetic wound repair. The hydrogel comprises two interpenetrating networks: A reversible, dynamic network formed via Zn2+-coordinated GA confers excellent injectability and conformability, allowing tight adherence to irregular wound topographies. A secondary, physically cross-linked network is introduced by ultraviolet (UV)-induced polymerization of methacrylated hyaluronic acid (HAMA), which significantly reinforces mechanical strength and structural stability. GA exhibits inherent immunomodulatory activity, promoting macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, thereby attenuating local inflammation. Concurrently, FE provides a rich reservoir of pro-angiogenic and regenerative bioactive factors that synergistically promote neovascularization and tissue remodeling. In vitro and in vivo evaluations confirmed that this composite hydrogel accelerates wound closure, reduces inflammatory cytokine expression, enhances angiogenesis, and promotes granulation tissue formation. Collectively, this injectable, immunomodulatory, and pro-regenerative hydrogel platform offers a promising therapeutic strategy for the effective management of recalcitrant diabetic wounds.